MUDR. Zuzana URBANOVA

The research at MUDR. Zuzana URBANOVA targets autoimmune conditions, with a focus on rheumatoid arthritis, aiming to test new oral therapies that may improve symptom control and reduce joint damage.

• Evaluation of novel JAK inhibitor therapy for rheumatoid arthritis
• Comparison of oral agents with established biologic treatments
• Assessment of long‑term safety in patients with inadequate response to methotrexate

The site in Prague is conducting a small portfolio of trials to explore more effective treatment options for patients with immune‑mediated arthritis.

Studies at the clinic also address axial spondyloarthritis, including both radiographic and non‑radiographic forms, to evaluate whether new oral compounds can lessen inflammation and slow structural progression.

• Testing efficacy of oral agents in active axial spondyloarthritis
• Monitoring safety and tolerability in patients previously treated with biologics
• Investigating impact on disease progression and functional outcomes

With three active trials and two investigators, the Prague facility is contributing valuable data to improve musculoskeletal health.